3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
4
Breast Neoplasms
4
Sarcoma
3
Ovarian Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Hodgkin Disease
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Multiple Myeloma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Seminoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Osteosarcoma
1
Neoplasm Metastasis
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Ifosfamide
5
Filgrastim
5
Peripheral Blood Stem Cell Transplantation
4
Paclitaxel
4
Carboplatin
4
Etoposide
2
Cisplatin
2
tremelimumab
1
poly ICLC
1
pegfilgrastim
1
etoposide phosphate
1
durvalumab
1
Temozolomide
1
Radiotherapy
1
Microarray Analysis
1
Lenograstim
1
Immunohistochemistry
1
Gemcitabine
1
ER 30346
1
Dasatinib
1
Blotting, Western
1
Beclomethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Testicular Neoplasms
×
pegfilgrastim
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled